Related Experiment Video

Updated: Jun 18, 2026

A Doxorubicin-Induced Murine Model of Dilated Cardiomyopathy In Vivo
05:14

A Doxorubicin-Induced Murine Model of Dilated Cardiomyopathy In Vivo

Published on: May 16, 2020

Activation of the ubiquitin-proteasome system in doxorubicin cardiomyopathy

Mark J Ranek, Xuejun Wang

    Current Hypertension Reports
    |November 10, 2009
    PubMed

    Insights

    Doxorubicin (Dox) chemotherapy can harm the heart by activating the ubiquitin-proteasome system (UPS). This system degrades crucial cardiac proteins, potentially explaining Dox-induced cardiotoxicity and offering new therapeutic targets.

    Area of Science:

    • Cardiology
    • Oncology
    • Molecular Biology

    Background:

    • Doxorubicin (Dox) is a vital chemotherapy drug with dose-dependent cardiotoxicity.
    • The precise mechanisms of Dox-induced cardiotoxicity are not fully understood, limiting prevention and treatment strategies.

    Purpose of the Study:

    • To review the current literature on Doxorubicin's impact on the ubiquitin-proteasome system (UPS).
    • To explore potential mechanisms by which UPS activation contributes to Dox-induced cardiotoxicity.

    Main Methods:

    • Literature review of studies investigating Doxorubicin and the UPS.
    • Analysis of experimental data linking UPS activation to cardiac remodeling.

    Main Results:

    • Doxorubicin therapy activates proteolysis in cardiomyocytes via the UPS.
    • Doxorubicin treatment enhances UPS-mediated degradation of key cardiac transcription and survival factors.
    • UPS activation is implicated in cardiac remodeling, similar to processes seen in hypertension.

    Conclusions:

    • Doxorubicin-induced UPS activation represents a potential novel mechanism of cardiotoxicity.
    • Understanding this pathway may lead to new strategies for preventing or managing Doxorubicin cardiotoxicity.

    More Related Videos

    A Doxorubicin-induced Cardiomyopathy Model in Adult Zebrafish08:09

    A Doxorubicin-induced Cardiomyopathy Model in Adult Zebrafish

    Published on: June 7, 2018

    Related Concept Videos

    Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

    Cardiomyopathy III: Hypertrophic Cardiomyopathy

    Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
    The Proteasome01:13

    The Proteasome

    Eukaryotic cells can degrade proteins through several pathways. One of the most important among these is the ubiquitin-proteasome pathway. It helps the cell eliminate the misfolded, damaged, or unwarranted cytoplasmic proteins in a highly specific manner.
    In this pathway, the target proteins are first tagged with small proteins called ubiquitin. This involves participation of a series of enzymes including— E1 (ubiquitin-activating enzyme), E2 (ubiquitin-conjugating enzyme), and E3 (ubiquitin...
    The Proteasome02:18

    The Proteasome

    Eukaryotic cells can degrade proteins through several pathways. One of the most important amongst these is the ubiquitin-proteasome pathway. It helps the cell eliminate the misfolded, damaged, or unwarranted cytoplasmic proteins in a highly specific manner.
    In this pathway, the target proteins are first tagged with small proteins called ubiquitin. A series of enzymes carry out the ubiquitination of the target proteins - E1 (ubiquitin-activating enzyme), E2 (ubiquitin-conjugating enzyme), and E3...
    Cardiomyopathy IV: Restrictive Cardiomyopathy01:29

    Cardiomyopathy IV: Restrictive Cardiomyopathy

    Restrictive cardiomyopathy (RCM) is a rare heart muscle disease characterized by impaired ventricular filling due to stiffened ventricular walls, leading to significant diastolic dysfunction.EtiologyRestrictive cardiomyopathy can arise from both inherited and acquired diseases, many of which are systemic. It is categorized into four main types: infiltrative, storage, non-infiltrative, and endomyocardial diseases.Infiltrative diseases, such as amyloidosis, lead to RCM by depositing amyloid...
    Cardiomyopathy II: Dilated Cardiomyopathy01:30

    Cardiomyopathy II: Dilated Cardiomyopathy

    Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
    Regulated Protein Degradation02:58

    Regulated Protein Degradation

    It is vital to regulate the activity of enzymatic as well as non-enzymatic proteins inside the cell. This can be achieved either through creating a balance between their rate of synthesis and degradation or regulating the intrinsic activity of the protein. Both these regulation mechanisms play an essential role in the normal functioning of cells.
    Protein degradation plays two important roles in the cells. It helps to protect cells from misfolded or damaged proteins before they lead to a...